Literature DB >> 7480178

Biological activities of cyanobacteria: evaluation of extracts and pure compounds.

B S Falch1, G M König, A D Wright, O Sticher, C K Angerhofer, J M Pezzuto, H Bachmann.   

Abstract

A total of 80 lipophilic and hydrophilic extracts obtained from 20 samples of cultured freshwater and terrestrial cyanobacteria were investigated for their biological activities. Of all the extracts, 26% exhibited a significant lethal effect against brine shrimp. Out of 54 extracts tested for antimicrobial activity, 78% showed antibacterial and 45% antifungal activities. Of 30 extracts tested for cytotoxicity against KB cells, none was found to be active. Bioassay-guided fractionation of the lipophilic extracts of Fischerella ambigua led to the isolation of three compounds; ambigols A (1) and B (2), and tjipanazole D (3). Compounds 1 and 2 exhibited antibacterial, antifungal, cytotoxic, molluscicidal, and anti-inflammatory, and antiviral activities. Tjipanazole D (3) showed moderate antibacterial properties.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7480178     DOI: 10.1055/s-2006-958092

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  25 in total

1.  Trichormamides C and D, antiproliferative cyclic lipopeptides from the cultured freshwater cyanobacterium cf. Oscillatoria sp. UIC 10045.

Authors:  Shangwen Luo; Hahk-Soo Kang; Aleksej Krunic; Wei-Lun Chen; Jilai Yang; John L Woodard; James R Fuchs; Sang Hyun Cho; Scott G Franzblau; Steven M Swanson; Jimmy Orjala
Journal:  Bioorg Med Chem       Date:  2015-05-01       Impact factor: 3.641

2.  The antimicrobial profile of extracts of a Phormidium-like cyanobacterium changes with phosphate levels.

Authors:  Nermin Adel El Semary
Journal:  World J Microbiol Biotechnol       Date:  2011-07-31       Impact factor: 3.312

Review 3.  Chemodiversity in freshwater and terrestrial cyanobacteria - a source for drug discovery.

Authors:  George E Chlipala; Shunyan Mo; Jimmy Orjala
Journal:  Curr Drug Targets       Date:  2011-10       Impact factor: 3.465

4.  Scytonemides A and B, cyclic peptides with 20S proteasome inhibitory activity from the cultured cyanobacterium Scytonema hofmanii.

Authors:  Aleksej Krunic; Armelle Vallat; Shunyan Mo; Daniel D Lantvit; Steven M Swanson; Jimmy Orjala
Journal:  J Nat Prod       Date:  2010-11-08       Impact factor: 4.050

5.  Characterization of the Biocidal Spectrum of Extracellular Filtrates of Microcystis aeruginosa.

Authors:  Pranita Jaiswal; Radha Prasanna; Pawan K Singh
Journal:  Indian J Microbiol       Date:  2011-01-25       Impact factor: 2.461

6.  Sanctolide A, a 14-membered PK-NRP hybrid macrolide from the cultured cyanobacterium Oscillatoria sancta (SAG 74.79).

Authors:  Hahk-Soo Kang; Aleksej Krunic; Jimmy Orjala
Journal:  Tetrahedron Lett       Date:  2012-05-03       Impact factor: 2.415

7.  In vitro antibacterial evaluation of Anabaena sp. against several clinically significant microflora and HPTLC analysis of its active crude extracts.

Authors:  Abhishek Chauhan; Garima Chauhan; Prakash C Gupta; Pankaj Goyal; P Kaushik
Journal:  Indian J Pharmacol       Date:  2010-04       Impact factor: 1.200

8.  Minutissamides E-L, antiproliferative cyclic lipodecapeptides from the cultured freshwater cyanobacterium cf. Anabaena sp.

Authors:  Hahk-Soo Kang; Megan Sturdy; Aleksej Krunic; Hyunjung Kim; Qi Shen; Steven M Swanson; Jimmy Orjala
Journal:  Bioorg Med Chem       Date:  2012-08-22       Impact factor: 3.641

9.  In vitro antibacterial activity of laboratory grown culture of Spirulina platensis.

Authors:  P Kaushik; Abhishek Chauhan
Journal:  Indian J Microbiol       Date:  2009-03-25       Impact factor: 2.461

10.  Ribocyclophanes A-E, Glycosylated Cyclophanes with Antiproliferative Activity from Two Cultured Terrestrial Cyanobacteria.

Authors:  Daniel S May; Hahk-Soo Kang; Bernard D Santarsiero; Aleksej Krunic; Qi Shen; Joanna E Burdette; Steven M Swanson; Jimmy Orjala
Journal:  J Nat Prod       Date:  2018-01-30       Impact factor: 4.050

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.